Navigation Links
ETHEX Corporation Issues Nationwide Voluntary Recall of Products
Date:1/28/2009

80 Tablets (58177-413-04) Guaifenex PSE 85 Tablets (58177-478-04) Hista-Vent DA Tablets (58177-227-04) Hista-Vent PSE tablets (58177-426-04) Histinex HC Liquid (58177-877-07 & 877-12) Histinex PV Liquid (58177-883-07) Hydrocodone Bitartrate & Acetaminophen Liquid (58177-909-07) Hydrocodone Bitartrate/Guaifenesin Liquid (58177-881-07) Hydrocortisone and Iodoquinol Cream, 1% (58177-803-02) Hydroquinone 4% Cream w/SS, 1oz. (58177-802-02) Hydroquinone 4% Cream, 1oz. (58177-801-02) Hydro-Tussin CBX Liquid (58177-924-07) Hydro-Tussin DHC Syrup (58177-926-07) Hydro-Tussin DM Liquid (58177-906-07) Hydro-Tussin EXP Liquid (58177-927-07) HydroTussin HC Syrup (58177-915-07) Hydro-Tussin Liquid (58177-890-07) Hydro-Tussin XP Liquid (58177-916-07) Hyoscyamine Orally Disintegrating Tablets, .125mg (58177-423-04) Hyoscyamine Sublingual Tablets, .125mg (58177-255-04) Hyoscyamine Sulfate ER Tablets, .375mg (58177-237-04) Hyoscyamine Sulfate ER Capsules, .375mg (58177-017-04) Hyoscyamine Sulfate Oral Tablets, .125mg (58177-274-04) Isosorbide Mononitrate ER Tablets, 120mg (58177-201-04) Isosorbide Mononitrate ER Tablets, 30mg (58177-222-04, 222-08 & 222-11) Isosorbide Mononitrate ER Tablets, 60mg (58177-238-04, 238-08 & 238-11) Meperidine/Promethazidne Capsules (58177-027-04) Morphine InveAmp, 20mg x 1mL (58177-886-56) Morphine InveAmp, 5mg/.25mL (58177-888-80) Morphine Sulfate Concentrated Oral Solution 20mg/1ml (58177-886-01, 886-03 &886-05) Morphine Sulfate Concentrated Oral Solution, 20mg/1ml (58177-886-57) Morphine Sulfate ER Tablets, 100mg (58177-340-04) Morphine Sulfate ER Tablets, 15mg (58177-310-04) Morphine Sulfate ER Tablets, 200mg (58177-380-04) Morphine Sulfate ER Tablets, 30mg (58177-320-04) Morphine Sulfate ER Tablets, 60mg (58177-330-04) Morphine Sulfate IR Tablet
'/>"/>
SOURCE KV Pharmaceutical
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. ETHEX Corporation Voluntarily Recalls Specific Lots of 30 mg. and 60 mg. Morphine Sulfate Extended Release Tablets Due to the Potential for Oversized Tablets
2. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
3. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
4. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
5. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
6. BioElectronics Corporation Announces Singapore and Malaysia Sales
7. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
8. DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference
9. Insulet Corporation to Present at the Thomas Weisel Partners Healthcare Conference on September 6, 2007
10. Luminex Corporation to Present at Thomas Weisel Partners Healthcare Conference
11. Verenium Corporation to Present at the Upcoming Cowen and Company Clean Energy Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... ... August 27, 2015 , ... Inc. Magazine released its ... iLab Solutions as number 1,361 in growth for the three years through 2014. Being ... 0.1% fastest-growing privately held organizations in the country. , “We are thrilled to ...
(Date:8/27/2015)... ... August 27, 2015 , ... Proove Biosciences, ... on the relationship of genetics and hypertension at the International Academy of ... Vancouver, British Columbia, Canada. The event, which boasts an extensive overview of the ...
(Date:8/26/2015)... N.J. , Aug. 26, 2015  Roka Bioscience, ... focused on providing advanced testing solutions for the detection ... CEO will present at the Sidoti & Company Emerging ... conference will be held at the New York Marriott ... presentation will be available through the investor relations section ...
(Date:8/26/2015)... 2015  Platform therapeutic company Symic Biomedical, Inc. ... $1.5M Phase II SBIR grant from the National ... therapeutic agent to reduce arteriovenous fistula (AVF) failures, ... renal disease (ESRD) patients undergoing hemodialysis. The two-year ... and Digestive and Kidney Diseases (NIDDK), will allow ...
Breaking Biology Technology:iLab Solutions Named to 2015 Inc. 5000 List 2iLab Solutions Named to 2015 Inc. 5000 List 3Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 2Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 3Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3
... CHENGDU, China, Sept. 17 /PRNewswire-Asia-FirstCall/ -- Tianyin,Pharmaceutical, Co., Inc., ... of,modernized traditional Chinese medicine (,TCM,) based in Chengdu, China, ... discuss its fiscal,2009 fourth quarter and full year results ... Interested parties may access the ...
... ... liquid medications, pharmacists are prepared to help children successfully take antiviral medications to fight the ... children are more likely to take their medicine as prescribed. , ... Columbia, MD, (PRWEB) September 17, 2009 -- As new ...
... ... software industries, among others , ... Boston, Massachusetts (Vocus) -- Brown Rudnick, an international law firm, today announced ... the Firm,s Boston office. With over 35 years of combined experience, the team includes ...
Cached Biology Technology:Tianyin Pharmaceutical Co., Inc. to Host Fiscal 2009 Earnings Conference Call on Thursday, September 24, 2009 at 10:30 a.m. ET 2FLAVORx Helps Families Fight Pandemic H1N1 Influenza Virus By Making Antiviral Medicine Taste Better 2FLAVORx Helps Families Fight Pandemic H1N1 Influenza Virus By Making Antiviral Medicine Taste Better 3FLAVORx Helps Families Fight Pandemic H1N1 Influenza Virus By Making Antiviral Medicine Taste Better 4Veteran Intellectual Property Team Joins Brown Rudnick 2
(Date:8/18/2015)... N.J. , Aug. 18, 2015 /PRNewswire/ ... a key contributor to the Submission Content ... by IRISS, a non-profit forum. Dedicated to the ... provides a neutral platform for industry, vendors, ... share information and work towards a standard ...
(Date:8/17/2015)... 17, 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market and creator of ... for Q4 2015. The new marketing campaign is being ... Amplitude Marketing Group ( http://amplitudemarketing.com/ ) and TPMG ( ... leader in retail driven marketing and brand awareness and ...
(Date:8/12/2015)... 12, 2015 As the digital ... innovation and advanced biometrics technology is accelerating beyond expectations.  ... rely on using their credit cards, the digital currency, ... for payment services led by companies in the space ... Google, Inc. (NASDAQ: GOOG ), Apple Inc. (NASDAQ: ...
Breaking Biology News(10 mins):Navitas, a Key Contributor in IRISS Forum Webinar 2Navitas, a Key Contributor in IRISS Forum Webinar 3NXT-ID, Inc. Launches Sales Campaign for Wocket Smart Wallet with Award Winning Marketing Team 2NXT-ID, Inc. Launches Sales Campaign for Wocket Smart Wallet with Award Winning Marketing Team 3Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 2Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 3Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 4Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 5Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 6
... WASHINGTON, DC, JULY 7, 2008 -- The Soil Science ... by Senator Sherrod Brown and his colleagues in the ... as an "essential" natural resource, placing soil on par ... Brown was joined by co-sponsoring Senators Kent Conrad (D-ND), ...
... of cancer continues to pose a major problem for ... of chemotherapy or become resistant to the medication. Scientists ... Braunschweig, the Hannover Medical School (MHH) and Leibniz-Universitt (LUH) ... which a natural substance - argyrin - destroys tumours. ...
... MADISON, WI, JULY 6, 2008 -- Swine production generates ... that may serve as fertilizer when applied to agricultural ... different than what a crop requires. Application of waste ... in application of excess phosphorus which increases the potential ...
Cached Biology News:Senate resolution shines spotlight on the importance of soils 2Argyrin: Natural substance raises hope for new cancer therapies 2
Mouse polyclonal antibody to REXO4 - XPMC2 prevents mitotic catastrophe 2 homolog (Xenopus laevis)...
... Stabilizer is an aqueous solution that contains ... chemicals in a PBS buffer (phosphate buffered ... product contains a combination of 0.02% methylisothiazolone ... StabilCoat Plus Stabilizer provides optimum performance for ...
... designed for quick and easy protein purification ... two 0.25mm holes laser cut at the ... remain liquid-tight during incubation of the gel ... protein diffuses from the gel into the ...
... design specifically for western blots ,• Optically ... designed for staining western blots. The reduced ... of the disposable tray requires less dye ... savings to the user. Pour spouts in ...
Biology Products: